Posted by John Deo
Verona Pharma plc (NASDAQ:VRNA) is a pharmaceutical company focused on developing and commercializing innovati
Source: Two Blokes Trading
Posted by John Deo
AnaptysBio, Inc. (NASDAQ:ANAB) is a biotechnology company focused on developing antibody therapeutics for infl
Source: Two Blokes Trading
Posted by John Deo
Herbalife's ROIC of 33.60% significantly exceeds its WACC of 19.01%, indicating efficient capital utilization
Source: Two Blokes Trading
Posted by John Deo
Earnings Per Share (EPS) is estimated at $0.01, with revenue projections of approximately $222.3 million, mar
Source: Two Blokes Trading
Posted by John Deo
Earnings per Share (EPS) of $0.3054 was below the estimated $0.39, indicating challenges in profitability. Re
Source: Two Blokes Trading
Posted by John Deo
UiPath Inc. (NYSE:PATH) is set to release its quarterly earnings on March 12, 2025, with an estimated EPS
Source: Two Blokes Trading
Posted by John Deo
Earnings per Share (EPS) of $3.62, beating the estimated $3.55. Revenue reached approximately $3.89 billion,
Source: Two Blokes Trading
Posted by John Deo
Introduction Recent U.S. tariff measures announced by President Donald Trump have rattled global markets, con
Source: Two Blokes Trading
Posted by John Deo
Goldman Sachs analysts forecast that S&P 500 dividends will grow by 6% year-over-year in 2025, even as the
Source: Two Blokes Trading
Posted by John Deo
JPMorgan analysts caution that ongoing tariff uncertainty remains a significant risk for markets, particularly
Source: Two Blokes Trading
Posted by John Deo
European stocks are trading at a near-record discount relative to U.S. equities, presenting a unique opportuni
Source: Two Blokes Trading
Posted by John Deo
Evercore ISI analysts issued a cautionary note on Monday, warning that mounting stagflation fears could pose s
Source: Two Blokes Trading